Dynavax Technologies Corporation
IMMUNOGENIC COMPOSITION AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
Last updated:
Abstract:
The present invention relates to an immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), especially to an immunogenic composition having a recombinant SARS-CoV-2 S protein and adjuvant.
Status:
Application
Type:
Utility
Filling date:
18 Jun 2021
Issue date:
7 Oct 2021